Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Daiichi Sankyo
Cipla
Colorcon
Express Scripts
Fish and Richardson
AstraZeneca
Federal Trade Commission

Generated: June 25, 2018

DrugPatentWatch Database Preview

SARENIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Sarenin patents expire, and what generic alternatives are available?

Sarenin is a drug marketed by Procter And Gamble and is included in one NDA.

The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.
Summary for SARENIN
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 18
Patent Applications: 820
DailyMed Link:SARENIN at DailyMed
Drug patent expirations by year for SARENIN
Medical Subject Heading (MeSH) Categories for SARENIN
Synonyms for SARENIN
(1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II
(Sar1,Val5,Ala8)Angiotensin II
[Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate
[Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate, >=97% (HPLC), powder
1-Sar-8-Ala Angiotensin II
1-Sarcosine-8-Alanine Angiotensin II
2-[[1-[2-[[2-[[2-[[2-[[5-(diaminomethylideneamino)-2-[(2-methylaminoacetyl)amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2
2-[[1-[2-[[2-[[2-[[2-[[5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine
34273-10-4 (Parent)
39698-78-7
AC1L1WBL
ACETIC ACID SARALASIN HYDRATE
AM023433
Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
CHEMBL1200670
CHEMBL356431
D00VFE
D04126
D0K0AT
FO21Z580M4
GTPL598
L000747
LS-174459
N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine
NCGC00166135-01
P-113
P-113 Acetate
Sar-Arg-Val-Tyr-Val-His-Pro-Ala
Saralasin [INN:BAN]
Saralasin acetate
Saralasin acetate (USAN)
Saralasin acetate [USAN]
Saralasin acetate hydrate
Saralasin Acetate, Hydrated
Saralasina [INN-Spanish]
Saralasine [INN-French]
Saralasinum [INN-Latin]
Sarenin (TN)
SCHEMBL2200145
UNII-FO21Z580M4

US Patents and Regulatory Information for SARENIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for SARENIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
AstraZeneca
Boehringer Ingelheim
Argus Health
Cipla
Mallinckrodt
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.